Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant <i>Klebsiella pneumoniae</i>

Evaluation of the Organotellurium Compound AS101 for Treating Colistin- and Carbapenem-Resistant <i>Klebsiella pneumoniae</i>

Colistin- and carbapenem-resistant <i>Enterobacteriaceae</i> cases are increasing at alarming rates worldwide. Drug repurposing is receiving greater attention as an alternative approach in light of economic and technical barriers in antibiotics research. The immunomodulation agent ammoni...

Full description

Bibliographic Details
Main Authors: Tsung-Ying Yang, Hao-Yun Kao, Po-Liang Lu, Pei-Yu Chen, Shu-Chi Wang, Liang-Chun Wang, Ya-Ju Hsieh, Sung-Pin Tseng
Format: Article
Language:English
Published: MDPI AG 2021-08-01
Series:Pharmaceuticals
Subjects:
carbapenem resistance
colistin resistance
<i>Klebsiella pneumoniae</i>
sepsis mouse model
AS101
drug repurposing
Online Access:https://www.mdpi.com/1424-8247/14/8/795

Internet

https://www.mdpi.com/1424-8247/14/8/795

Similar Items